|
RALA expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 6.085200E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.178400E-01 |
| Normal-vs-Stage2 |
3.436200E-01 |
| Normal-vs-Stage3 |
8.160800E-01 |
| Normal-vs-Stage4 |
8.020600E-01 |
| Stage1-vs-Stage2 |
5.526800E-01 |
| Stage1-vs-Stage3 |
4.229000E-01 |
| Stage1-vs-Stage4 |
8.954800E-01 |
| Stage2-vs-Stage3 |
3.277200E-01 |
| Stage2-vs-Stage4 |
6.097200E-01 |
| Stage3-vs-Stage4 |
6.869000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.320400E-01 |
| Normal-vs-AfricanAmerican |
8.918200E-01 |
| Normal-vs-Asian |
7.738600E-01 |
| Caucasian-vs-AfricanAmerican |
9.534600E-01 |
| Caucasian-vs-Asian |
9.620800E-01 |
| AfricanAmerican-vs-Asian |
9.259200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
6.124200E-01 |
| Normal-vs-Female |
6.534000E-01 |
| Male-vs-Female |
8.663800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.280800E-01 |
| Normal-vs-Age(41-60Yrs) |
4.329600E-01 |
| Normal-vs-Age(61-80Yrs) |
4.303600E-01 |
| Normal-vs-Age(81-100Yrs) |
7.496000E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
3.335000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.665000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.492000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.294200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.626400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.502800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
5.818300E-03 |
| Classical-VS-Follicular |
6.45550000000217E-05 |
| Classical-VS-Other |
2.134400E-01 |
| Classical-VS-Normal |
6.951000E-01 |
| Tall-VS-Follicular |
3.06770000002565E-06 |
| Tall-VS-Other |
3.142400E-02 |
| Tall-VS-Normal |
1.414470E-02 |
| Follicular-VS-Other |
9.306200E-01 |
| Follicular-VS-Normal |
2.918100E-03 |
| Other-VS-Normal |
1.590960E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.185800E-02 |
| Normal-vs-N1 |
5.508800E-01 |
| N0-vs-N1 |
6.579600E-01 |
|
|
